Rituximab, a lower-cost treatment, may be as effective at managing RRMS as the approved therapy Ocrevus, a new study from ...

The clinical experts explained that ocrelizumab and ofatumumab are considered high-efficacy DMTs, and that these were the most relevant comparators for cladribine. While ponesimod is also considered ...

Tolebrutinib, a brain-penetrant BTK inhibitor, may fill a significant unmet need by delaying disability progression in patients with non-relapsing secondary progressive multiple sclerosis.

Meanwhile, a new generation of drugs such as Roche’s fast-growing Ocrevus (ocrelizumab) infusion – which had sales of around $3.7 billion last year – won’t be shifted without a fight.

That could give the drugs an advantage over CD20-targeting therapies like Roche's Ocrevus (ocrelizumab) that inhibit B cells across the board, leaving patients prone to infections and other side ...

No difference in incidence of AEs RCT [55] Ocrelizumab + MMF/CY Complete and partial renal response rates were 67% in ocrelizumab versus 55% in placebo group (p = NS). No difference between MMF ...

Ocrevus (ocrelizumab) for multiple sclerosis; N6LS and cabotegravir to treat HIV; DARZALEX to treat amyloidosis, and smoldering and multiple myeloma; Epinephrine Injection to treat allergic ...

Dr Pavan Bhargava gives insights on earlier diagnosis, ocrelizumab safety in pregnancy, and promising anti-aging effects of diet in RRMS.

MS patients in rural areas are 17% less likely to receive DMTs than those in urban areas, a study of Alberta, Canada, ...